Advertisement
Organisation › Details
Consilium Strategic Communications Ltd. (CSC)
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects. *
Start | 2013-07-25 splitoff | |
End | 2023-09-12 renamed | |
Group | ICR (Group) | |
Today | ICR Consilium Strategic Communications | |
Successor | ICR Consilium Strategic Communications | |
Industry | public relations / investor relations / marcom (services) | |
Industry 2 | healthcare | |
Person | Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) | |
Person 2 | Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder) | |
Street | 41 Lothbury | |
City | EC2R 7HG London | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London. | ||
Record changed: 2024-03-30 |
Advertisement
More documents for ICR (Group)
- [1] Philogen S.p.A.. (5/13/19). "Press Release: Philogen Announces €62 Million Financing Round". Siena....
- [2] Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich....
- [3] Consilium Strategic Communications Ltd.. (7/17/18). "Press Release: Consilium Strategic Communications Advises Polyphor on its Successful CHF 155 Million (c. €130 Million) Fundraise and IPO on the SIX Swiss Exchange". London....
- [4] Tricares SAS. (6/4/18). "Press Release: Tricares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimally Invasive Treatment of Tricuspid Regurgitation". Paris & Munich....
- [5] BioNTech AG. (12/21/17). "Press Release: BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference". Mainz....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top